01. July 2012.
Dr. Ronald Seeliger assumes the position of the Managing Director of Hemofarm as of July 1st 2012.
Ronald Seeliger has been a member of STADA Group management since August 2011. He has been gaining corporate experience in numerous leading companies in Germany and Western Europe, including: RUHR 2010, Pixelpark, Formula 1, Germany Land of Ideas, Rockitbiz. He graduated from the Technical University in Berlin (Technischen Universität Berlin), completed London School of Economy, and earned a doctor’s degree in engineering at the Technical University in Berlin.
Seeliger will take over from Wolfram Heinisch, who will assume the position of STADA Group Vice President Strategy Planning & Business Intelligence. Wolfram Heinisch was appointed Managing Director and Chairman of the Executive Board of Hemofarm, i.e. Chairman of the Board of Directors of Hemofarm for Serbia and Western Balkans by the Decision of STADA Group Executive Board in 2010. He initiated and has actively participated in the implementation of the STADA Group project Build the Future and introduction of innovative business models, which resulted in a more balanced and reinforced portfolio of Hemofarm, transfer of production of a large number of STADA’s products to Vršac, as well as the new corporate positioning.
